Patent · US Active

Heterocyclic antiestrogens

US10865199B2 · kind B2 · utility

0Cited by
5References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 26, 2016
Grant dateDec 15, 2020
Priority date
Expiry dateOct 26, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D335/06
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present invention provides novel heterocyclic compounds as anticancer agents, especially as estrogen receptor (ER) antagonists/degraders and process for their preparation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.